Published in Law.com
Written By: Amanda Bronstad
[Kila Baldwin is one of the leaders of the Anapol Weiss Women’s Health Litigation Team. She is currently preparing cases to file against Pfizer on behalf of women who have had brain or spinal cord tumors (meningiomas) and who were on Depo-Provera for a year or more.]
Excerpts from the article in Law.com:
In March, neurosurgeons and researchers in France published a large case control study in the British Medical Journal that found women who continually took the contraceptive Depo-Provera had a 550% higher chance of developing brain tumors.
Since the study came out, plaintiffs firms have been taking calls from women who took Depo-Provera and were diagnosed with a form of brain tumor called intracranial meningioma. Now, lawsuits are starting to take shape, and some of them may find a home in Philadelphia.
"There's going to be a push, likely, to get these cases into Philadelphia," Anapol Weiss shareholder Kila Baldwin said.
That's because one of the generic manufacturer defendants, Viatris Inc., is headquartered in Canonsburg, Pennsylvania. Baldwin said the Pennsylvania connection makes Philadelphia a potential site for lawsuits over the drug.
"It could be big. I think it could be as big as some of the others we've gotten here," Baldwin said.
Click here to read the full article on Law.com
